Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q3 2022 call → NOWe need to determine if management explains the company's business direction by narrating what its counterparties are themselves doing and scaling. The key is whether management's forward account is substantially about the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, etc., that the company already supplies, and that this is early and large relative to the company. Let's examine the transcript. Management discusses demand drivers: residential construction, repair/remodel, infrastructure. They mention "homes that were started could have been completed" due to supply chain issues, but that's about homebuilders' constraints, not their expansion. They talk about "unprecedented migration" to southern markets, but that's macro. They mention "field trials underway with our customer base" for PLC, but that's about product acceptance, not counterparties' scaling. They discuss "DOTs" but not their specific programs. They mention "large jobs were delayed" in aggregates, but that's about delays, not growth. Management's forward outlook is based on broad demand fundamentals: residential, infrastructure, pricing, capacity. They do not narrate specific counterparties' own ramps or expansions. They talk about their own investments, pricing, and capacity. The only mention of counterparties is general: "homebuilders," "customers," "DOTs," but no specific trajectories. They don't describe a particular customer's build-out as driving their volumes. They mention "our key southern tier markets are in fact seeing unprecedented migration" but that's macro. Thus, the answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.